mhurhangee/patent-ind-claim-en huggingface dataset:
Polyisocyanate mixture comprising at least one polyisocyanurate which is based on tolylene diisocyanate and has isocyanate groups and at least one polyurethane which is based on tolylene diisocyanate and has isocyanate groups, wherein the polyisocyanate mixture has a) a solids content of from ≥ 51 to ≤ 90% by weight, based on the total weight of the polyisocyanate mixture, the solids content being determined in accordance with DIN EN ISO 3251 using a drying temperature and time of 2 hours at 120°C and a test dish diameter of 75 mm and a weighed-in quantity of 2.00 g +/- 0.02, b) a content of monomeric tolylene diisocyanate of ≤ 0.9% by weight, based on the total weight of the polyisocyanate mixture, the content of monomeric tolylene diisocyanate being determined gas-chromatographically using an internal standard in accordance with DIN EN ISO 10283:2007-11, and the polyisocyanurate which is based on tolylene diisocyanate and has isocyanate groups has a polydispersity D of from ≥ 1 to ≤ 1.5, based on the total weight of the polyisocyanurate which is based on tolylene diisocyanate and has isocyanate groups, where the polydispersity D is the ratio of weight average and number average molecular weight of the polyisocyanurate and the weight average and number average molecular weight is in each case determined by means of gel permeation chromatography using a polystyrene standard and tetrahydrofuran as eluent in accordance with DIN 55672-1:2016-03. a) a solids content of from ≥ 51 to ≤ 90% by weight, based on the total weight of the polyisocyanate mixture, the solids content being determined in accordance with DIN EN ISO 3251 using a drying temperature and time of 2 hours at 120°C and a test dish diameter of 75 mm and a weighed-in quantity of 2.00 g +/- 0.02, b) a content of monomeric tolylene diisocyanate of ≤ 0.9% by weight, based on the total weight of the polyisocyanate mixture, the content of monomeric tolylene diisocyanate being determined gas-chromatographically using an internal standard in accordance with DIN EN ISO 10283:2007-11, and
A tunable optical add/drop multiplexer, T-OADM, comprising a first wavelength control unit , a second wavelength control unit and two grating-assisted filters, GAFs, and the first wavelength control unit is connected to the first GAF , the second wavelength control unit is connected to a second GAF ; the first GAF comprises an input port, an output port, a drop port, and an add port; the second GAF comprises an input port, an output port, a drop port, and an add port; the drop port of the first GAF , is configured to connect to the input port of the second GAF , and the add port of the first GAF is configured to connect to the output port of the second GAF ; the input port of the first GAF of the T-OADM is configured to receive light waves of a plurality of wavelengths, wherein the light waves of a plurality of wavelengths comprise a first light wave; the first GAF , is configured to transmit the first light wave to the input port of the second GAF through the drop port of the first GAF ; the first wavelength control unit , is configured to change a dropped spectrum of the first GAF by controlling voltage based on first amplitude of wavelength shift to tune a passband center wavelength of the first GAF , wherein a passband center wavelength of the first GAF is the same as a passband center wavelength of the second GAF ; the second wavelength control unit , is configured to change a dropped spectrum of the second GAF by controlling voltage based on second amplitude of wavelength shift, to obtain a first light wave response, wherein the second amplitude is different from the first amplitude; and the drop port of the second GAF , is configured to output a first target light wave of a first target bandwidth, wherein the first target bandwidth is an overlapping spectral linewidth of the first light wave and the first light wave response.
A method for manufacturing a back side illuminated photodetector comprising: forming an assembly of layers including an InP cap layer on an InGaAs absorption region layer , wherein the InGaAs layer is on an n-InP layer , and wherein an underlying substrate layer underlies the n-InP layer , wherein a sacrificial layer is located between and in direct contact with the n-InP layer and the substrate layer ; and thinning the InP cap layer by dry etching to a thickness of equal to or less than one hundred nanometers; wherein the n-InP layer is a contact layer for the back side illuminated detector, and further comprising: removing the substrate layer by chemical/mechanical polishing, selective wet etching of the substrate layer and the sacrificial layer ; dry etching a portion of the n-InP layer away; and dry etching at least one of the InP cap layer or the n-InP layer down to a final thickness of 10nm. forming an assembly of layers including an InP cap layer on an InGaAs absorption region layer , wherein the InGaAs layer is on an n-InP layer , and wherein an underlying substrate layer underlies the n-InP layer , wherein a sacrificial layer is located between and in direct contact with the n-InP layer and the substrate layer ; and thinning the InP cap layer by dry etching to a thickness of equal to or less than one hundred nanometers; wherein the n-InP layer is a contact layer for the back side illuminated detector, and further comprising: removing the substrate layer by chemical/mechanical polishing, selective wet etching of the substrate layer and the sacrificial layer ; dry etching a portion of the n-InP layer away; and dry etching at least one of the InP cap layer or the n-InP layer down to a final thickness of 10nm. removing the substrate layer by chemical/mechanical polishing, selective wet etching of the substrate layer and the sacrificial layer ; dry etching a portion of the n-InP layer away; and dry etching at least one of the InP cap layer or the n-InP layer down to a final thickness of 10nm.
A pharmaceutical product comprising fluticasone furoate for use in a method for reducing the rate of decline in lung function in a patient with COPD, wherein the patient has a blood eosinophil count >2%, and wherein the pharmaceutical product is a dry powder inhaler or pressurised metered dose inhaler.
A method of suppressing non-specific protein adsorption, the method comprising the steps of: (i) treating a solid phase with a solid phase-treating liquid containing a phosphorylcholine group-containing polymer as a main component; and (ii) treating a specimen with a specimen-treating liquid containing, as a main component, a copolymer having three separate components selected from a phosphorylcholine group, a hydroxy group, and a hydrophobic group, followed by addition of the treated specimen to the solid phase treated in the step (i), or (iii) treating a specimen with a specimen-treating liquid containing, as a main component, a copolymer having three separate components selected from a phosphorylcholine group, a hydroxy group, and a hydrophobic group; and (iv) treating a solid phase with a solid phase-treating liquid containing a phosphorylcholine group-containing polymer as a main component, followed by addition of the specimen treated in the step (iii) to the treated solid phase. (i) treating a solid phase with a solid phase-treating liquid containing a phosphorylcholine group-containing polymer as a main component; and (ii) treating a specimen with a specimen-treating liquid containing, as a main component, a copolymer having three separate components selected from a phosphorylcholine group, a hydroxy group, and a hydrophobic group, followed by addition of the treated specimen to the solid phase treated in the step (i), or (iii) treating a specimen with a specimen-treating liquid containing, as a main component, a copolymer having three separate components selected from a phosphorylcholine group, a hydroxy group, and a hydrophobic group; and (iv) treating a solid phase with a solid phase-treating liquid containing a phosphorylcholine group-containing polymer as a main component, followed by addition of the specimen treated in the step (iii) to the treated solid phase.
A polymeric composition comprising: a) at least one thermoplastic polymer; and b) 2-30 wt% graphite flakes that are coated with silica coating particles, with the total weight of the composition totaling to 100 wt%, wherein the coated graphite flakes have a weight ratio of C:Si ranging from 10:1-4:1, measured according to the method disclosed in the description by an Energy Dispersive Spectrometer, and the silica particles have an average diameter of 80-400 nm, measured according to the method disclosed in the description by a scanning electron microscope (SEM).
A component determination system configured to determine, in a case when a first component to be mounted on a first side of a board by a first mounting operation and a second component mounted on the second side of the board by a second mounting operation have a particular corresponding relationship, whether a combination of the first component and the second component mounted is permissible, the component determination system comprising: a first characteristic information acquiring section configured to acquire first characteristic information of the first component for which the first mounting operation has been completed; a second characteristic information acquiring section configured to acquire second characteristic information of the second component prepared prior to the second mounting operation; and a combination determining section configured to determine whether to allow the combination of the first component and the second component based on the acquired first characteristic information and the acquired second characteristic information, wherein the particular corresponding relationship of the first component and the second component is that they are the same part type, and the first characteristic information and the second characteristic information are at least one of a packaging identification number identifying a packaging that holds multiple of the components, a lot number identifying a lot of multiple of the packagings, or a manufacturer of the components. a first characteristic information acquiring section configured to acquire first characteristic information of the first component for which the first mounting operation has been completed; a second characteristic information acquiring section configured to acquire second characteristic information of the second component prepared prior to the second mounting operation; and a combination determining section configured to determine whether to allow the combination of the first component and the second component based on the acquired first characteristic information and the acquired second characteristic information, wherein the particular corresponding relationship of the first component and the second component is that they are the same part type, and the first characteristic information and the second characteristic information are at least one of a packaging identification number identifying a packaging that holds multiple of the components, a lot number identifying a lot of multiple of the packagings, or a manufacturer of the components.
A system comprising: at least three balloons (802A-D), wherein each balloon comprises a position-determining module, PDM, (804A-D) and a position-broadcasting module, PBM, (806A-D), wherein each PDM is configured to determine a position of the respective balloon, wherein each PBM is configured to broadcast a balloon signal containing balloon-positioning data of the respective balloon, the balloon-positioning data comprising (i) the determined position of the respective balloon and (ii) a corresponding time of broadcast, wherein one balloon of the at least three balloons is a first balloon, and the PDM of the first balloon is a first PDM, the first PDM being configured to determine a position of the first balloon based on a ground-based station (708A-C) and a celestial object , wherein one balloon of the at least three balloons is a second balloon, and the PDM of the second balloon is a second PDM, the second PDM being configured to determine a position of the second balloon by being configured to: determine a relative position of the second balloon with respect to the first balloon using an optical communication link between the first and second balloons; and determine a position of the second balloon based on the determined position of the first balloon and the determined relative position of the second balloon. at least three balloons (802A-D), wherein each balloon comprises a position-determining module, PDM, (804A-D) and a position-broadcasting module, PBM, (806A-D), wherein each PDM is configured to determine a position of the respective balloon, wherein each PBM is configured to broadcast a balloon signal containing balloon-positioning data of the respective balloon, the balloon-positioning data comprising (i) the determined position of the respective balloon and (ii) a corresponding time of broadcast, wherein one balloon of the at least three balloons is a first balloon, and the PDM of the first balloon is a first PDM, the first PDM being configured to determine a position of the first balloon based on a ground-based station (708A-C) and a celestial object , wherein one balloon of the at least three balloons is a second balloon, and the PDM of the second balloon is a second PDM, the second PDM being configured to determine a position of the second balloon by being configured to: determine a relative position of the second balloon with respect to the first balloon using an optical communication link between the first and second balloons; and determine a position of the second balloon based on the determined position of the first balloon and the determined relative position of the second balloon. determine a relative position of the second balloon with respect to the first balloon using an optical communication link between the first and second balloons; and determine a position of the second balloon based on the determined position of the first balloon and the determined relative position of the second balloon.
Antimicrobial agent containing as active ingredient a combination of 45 to 55% by weight benzyl isothiocyanate, 33 to 43% by weight allyl isothiocyanate and 7 to 17% by weight 2-phenylethyl isothiocyanate, wherein the total amount of the active ingredients adds up to 100% by weight, characterized in that the active ingredients are bound to an inert carrier substance and are enclosed in an airtight manner in an administration agent resistant to gastric juice, wherein the active ingredient combination bound to the inert carrier substance is pelletized and microencapsulated with chitosan.
Method for cleaning a jet engine, using a cleaning medium which contains solids which by means of a carrier gas and by way of at least one nozzle are introduced into the engine, the method characterized by the following features: a) the pressure of the carrier gas is 1 to 5 bar, preferably 2 to 4 bar; b) the exit of the at least one nozzle is disposed at a radial spacing from the rotation axis of the engine which corresponds to 0.6 to 1.2 times the radius of the entry opening of the first compressor stage that is directed upstream, c) the main exit direction of the nozzle in relation to the rotation axis of the engine encloses an angle of 10 to 30°, preferably of 12 to 25°, furthermore preferably of 16 to 19°. a) the pressure of the carrier gas is 1 to 5 bar, preferably 2 to 4 bar; b) the exit of the at least one nozzle is disposed at a radial spacing from the rotation axis of the engine which corresponds to 0.6 to 1.2 times the radius of the entry opening of the first compressor stage that is directed upstream, c) the main exit direction of the nozzle in relation to the rotation axis of the engine encloses an angle of 10 to 30°, preferably of 12 to 25°, furthermore preferably of 16 to 19°.
A compound of formula (I) wherein M is selected from -CH 2 - and -NR 7 -; R 1 and R 2 are each independently C 1-4 alkyl; R 3 is selected from the group consisting of hydrogen, halogen, hydroxy, C 1-4 alkyl, C 1-4 haloalkyl, C 1-4 alkoxy, cyano, nitro, amino, N -(C 1-4 alkyl)amino, N , N -di(C 1-4 alkyl)amino, N -(aryl-C 1-4 alkyl)amino, C 1-6 alkylcarbonylamino, C 3-6 cycloalkylcarbonylamino, N -(C 1-4 alkyl)aminocarbonyl, N , N -di(C 1-4 alkyl)aminocarbonyl, C 1-4 alkyloxycarbonylamino, C 3-6 cycloalkyloxycarbonylamino, C 1-4 alkylsulfonamido and C 3-6 cycloalkylsulfonamido; n is an integer 1, 2 or 3; R 4 is selected from the group consisting of hydrogen, halogen, cyano, C 1-4 alkyl, C 3-6 cycloalkyl, C 1-4 alkoxy, C 3-6 cycloalkyloxy, C 1-4 alkylthio, C 3-6 cycloalkylthio, amino, N -(C 1-4 alkyl)amino and N , N -di(C 1-4 alkyl)amino; One of R 5 and R 6 is carboxy, and the other of R 5 and R 6 is selected from the group consisting of hydrogen, fluoro, C 1-4 alkyl and C 1-4 haloalkyl; and R 7 is selected from the group consisting of hydrogen and C 1-4 alkyl; R 8 is selected from the group consisting of hydrogen and C 1-4 alkyl; or a pharmaceutically acceptable salt or a solvated or hydrated form thereof. M is selected from -CH 2 - and -NR 7 -; R 1 and R 2 are each independently C 1-4 alkyl; R 3 is selected from the group consisting of hydrogen, halogen, hydroxy, C 1-4 alkyl, C 1-4 haloalkyl, C 1-4 alkoxy, cyano, nitro, amino, N -(C 1-4 alkyl)amino, N , N -di(C 1-4 alkyl)amino, N -(aryl-C 1-4 alkyl)amino, C 1-6 alkylcarbonylamino, C 3-6 cycloalkylcarbonylamino, N -(C 1-4 alkyl)aminocarbonyl, N , N -di(C 1-4 alkyl)aminocarbonyl, C 1-4 alkyloxycarbonylamino, C 3-6 cycloalkyloxycarbonylamino, C 1-4 alkylsulfonamido and C 3-6 cycloalkylsulfonamido; n is an integer 1, 2 or 3; R 4 is selected from the group consisting of hydrogen, halogen, cyano, C 1-4 alkyl, C 3-6 cycloalkyl, C 1-4 alkoxy, C 3-6 cycloalkyloxy, C 1-4 alkylthio, C 3-6 cycloalkylthio, amino, N -(C 1-4 alkyl)amino and N , N -di(C 1-4 alkyl)amino; One of R 5 and R 6 is carboxy, and the other of R 5 and R 6 is selected from the group consisting of hydrogen, fluoro, C 1-4 alkyl and C 1-4 haloalkyl; and R 7 is selected from the group consisting of hydrogen and C 1-4 alkyl; R 8 is selected from the group consisting of hydrogen and C 1-4 alkyl; or a pharmaceutically acceptable salt or a solvated or hydrated form thereof.
A wireless IC device comprising: a wireless IC chip ; a power supply circuit board connected to the wireless IC chip and including a power supply circuit having a resonance circuit having a predetermined resonance frequency; and a radiation plate arranged to perform at least one of radiation of a transmission signal supplied from the power supply circuit, and receiving of a reception signal and supplying the reception signal to the power feeding circuit, wherein the power supply circuit board is provided with a second board-side electrode pattern, wherein the power supply circuit board is connected to the radiation plate by DC connection between the second board-side electrode pattern and the radiation plate , wherein a frequency of the transmission signal and a frequency of the reception signal are substantially determined on the basis of the resonance frequency of the resonance circuit; characterized by : the power supply circuit board being a multilayer board made of a plurality of dielectric layers (11A-G) or magnetic layers, and the resonance circuit being a lumped constant resonance circuit including a capacitor pattern and an inductor pattern. a wireless IC chip ; a power supply circuit board connected to the wireless IC chip and including a power supply circuit having a resonance circuit having a predetermined resonance frequency; and a radiation plate arranged to perform at least one of radiation of a transmission signal supplied from the power supply circuit, and receiving of a reception signal and supplying the reception signal to the power feeding circuit, wherein the power supply circuit board is provided with a second board-side electrode pattern, wherein the power supply circuit board is connected to the radiation plate by DC connection between the second board-side electrode pattern and the radiation plate , wherein a frequency of the transmission signal and a frequency of the reception signal are substantially determined on the basis of the resonance frequency of the resonance circuit; characterized by : the power supply circuit board being a multilayer board made of a plurality of dielectric layers (11A-G) or magnetic layers, and the resonance circuit being a lumped constant resonance circuit including a capacitor pattern and an inductor pattern. the power supply circuit board being a multilayer board made of a plurality of dielectric layers (11A-G) or magnetic layers, and the resonance circuit being a lumped constant resonance circuit including a capacitor pattern and an inductor pattern.
A water purifier comprising: a water purifier body provided with a filter for purifying raw water supplied from the outside, and for supplying purified water; a water discharge module of which at least a portion is coupled to protrude to the front of the water purifier body so that at least a portion thereof rotates or is elevated with respect to the water purifier body and which is provided with a water discharge nozzle , which is configured to supply the purified water supplied from the water purifier body to a user, in a lower end thereof; characterized by a driving unit for providing power required for the rotation and elevation of the water discharge module ; a detection unit (710. 720) installed in the water purifier body or the water discharge module to recognize a position and size of a container placed around the water purifier body ; and a control unit configured to receive position information and size information of the container from the detection unit to control the driving unit so that the water discharge nozzle moves above the container. a water purifier body provided with a filter for purifying raw water supplied from the outside, and for supplying purified water; a water discharge module of which at least a portion is coupled to protrude to the front of the water purifier body so that at least a portion thereof rotates or is elevated with respect to the water purifier body and which is provided with a water discharge nozzle , which is configured to supply the purified water supplied from the water purifier body to a user, in a lower end thereof; characterized by a driving unit for providing power required for the rotation and elevation of the water discharge module ; a detection unit (710. 720) installed in the water purifier body or the water discharge module to recognize a position and size of a container placed around the water purifier body ; and a control unit configured to receive position information and size information of the container from the detection unit to control the driving unit so that the water discharge nozzle moves above the container.
Use of a film composite (10; 110), encompassing a metal foil (12; 112) that is located closer to the film composite outer side (10b; 110b) or that constitutes the film composite outer side (10b; 110b), a polyolefin sealing film (16; 116) constituting the film composite inner side (10a; 110a), and a plastic barrier film (14; 114) located between the metal foil (12; 112) and the polyolefin sealing film (16; 116), to package packaged material containing fatty acid, in particular omega-3 fatty acid and/or omega-9 fatty acid, the plastic barrier film (14; 114) being a polyester film (14; 114), wherein the polyolefin sealing film (16; 116) is monoaxially or biaxially stretched in order to enhance the barrier effect.